Interferon and Ribavirin combination therapy in chronic hepatitis C: Predictors of sustained viral response

被引：0
|
作者：
Osowo, AT [1 ]
Jeevanantham, V [1 ]
Kothari, T [1 ]
机构：
[1] Unity Hlth Syst, Rochester, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00273
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
273
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [1] DURABILITY OF SUSTAINED VIROLOGIC RESPONSE IN COMBINATION THERAPY WITH INTERFERON/PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C
    Il Lee, Jung
    Lee, Jin-Woo
    Kim, Young Soo
    Shin, Yong Woon
    Lee, Don Hoeng
    Kim, Hyung Gil
    Jeong, Seok
    Park, Hyung Joo
    Park, Hyun Shin
    Hong, Soon-Sun
    [J]. HEPATOLOGY, 2008, 48 (04) : 906A - 907A
  • [2] Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland
    Innes, Hamish A.
    Hutchinson, Sharon J.
    Allen, Samuel
    Bhattacharyya, Diptendu
    Bramley, Peter
    Carman, Bill
    Delahooke, Toby E. S.
    Dillon, John F.
    Goldberg, David J.
    Kennedy, Nicholas
    Mills, Peter R.
    Morris, John
    Morris, Judith
    Robertson, Chris
    Stanley, Adrian J.
    Hayes, Peter
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (06) : 646 - 655
  • [3] Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Davis, G
    Esteban, R
    Albrecht, J
    Ling, M
    Group, I
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
  • [4] Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
    Asahina, Y
    Izumi, N
    Enomoto, N
    Uchihara, M
    Kurosaki, M
    Onuki, Y
    Nishimura, Y
    Ueda, K
    Tsuchiya, K
    Nakanishi, H
    Kitamura, T
    Miyake, S
    [J]. JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 623 - 629
  • [5] Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin
    Khokhar, N
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (04) : 471 - 472
  • [6] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    [J]. HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [7] Predictors of sustained response to alpha interferon therapy in chronic hepatitis C
    Martinot-Peignoux, M
    Boyer, N
    Pouteau, M
    Castelnau, C
    Giuily, N
    Duchatelle, V
    Aupérin, A
    Degott, C
    Benhamou, JP
    Erlinger, S
    Marcellin, P
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (02) : 214 - 223
  • [8] Predictors of sustained response to alpha interferon therapy in chronic hepatitis C
    Neuman, MG
    Benhamou, JP
    Martinot, M
    Boyer, N
    Shear, NH
    Malkiewicz, I
    Katz, GG
    Suneja, A
    Singh, S
    Marcellin, P
    [J]. CLINICAL BIOCHEMISTRY, 1999, 32 (07) : 537 - 545
  • [9] Hepatocellular Carcinoma after Sustained Viral Response to Interferon and Ribavirin Therapy in Cirrhosis Secondary to Chronic Hepatitis C
    Khokhar, Nasir
    Niazi, Tariq Khan
    Qureshi, Muhammad Omar
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2013, 23 (10): : 699 - 702
  • [10] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
12345